thanks to MS for the analyst's update. Summary below, largely reflects my earlier take.Analyst Note | by Johannes Faul Updated Jul 29, 2024No-moat Kogan’s June quarter 2024 earnings were better than we expected. Gross sales of AUD 184 million were slightly ahead of our AUD 177 million forecast due to a sooner-than-expected return to growth in the core Australian segment. EBITDA margins were much stronger than we anticipated, driven by operating leverage.
While operating cost control has improved, the next earnings leg-up depends on gross sales growth. We expect sales momentum to pick up in fiscal 2025 as consumers buy more online and household incomes rise. We forecast solid gross sales growth, averaging 7% per year over the next decade.
We maintain our AUD 10.70 fair value estimate, which is underpinned by our strong long-term earnings growth assumptions.
wazz
- Forums
- ASX - By Stock
- KGN
- Ann: Kogan.com - July 2024 Business Update
Ann: Kogan.com - July 2024 Business Update, page-36
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.85 |
Change
0.060(1.25%) |
Mkt cap ! $484.6M |
Open | High | Low | Value | Volume |
$4.74 | $4.86 | $4.72 | $891.6K | 186.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 235 | $4.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.86 | 1987 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 235 | 4.840 |
1 | 413 | 4.830 |
2 | 6774 | 4.800 |
1 | 1774 | 4.790 |
2 | 1030 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.860 | 1987 | 1 |
4.870 | 997 | 1 |
4.880 | 1011 | 1 |
4.890 | 2926 | 2 |
4.900 | 11602 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
KGN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online